MedTrace Logo

An Observational, Non-Interventional Trial to Assess Patient Satisfaction and Safety of Subsys™ Spray.

NCT01901718 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4

Last updated 2014-09-04

No results posted yet for this study

Summary

Chronic pain patients who experience breakthrough pain in the background of controlled persistent pain with opioids will be followed for 3 months in order to assess the safety and titration trends in the clinical practice setting of a novel fentanyl sublingual spray (Subsys™) for the treatment of breakthrough pain.

Conditions

  • Breakthrough Pain

Sponsors & Collaborators

  • International Clinical Research Institute

    lead OTHER

Principal Investigators

  • Srinivas Nalamachu, MD · International Clinical Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-12-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01901718 on ClinicalTrials.gov